Study design (if review, criteria of inclusion for studies)
Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
Participants
Cystic Fibrosis - 18 Years and older (Adult, Senior)
Interventions
Drug: MRT5005|Drug: Normal saline
Outcome measures
Types, frequency and severity of treatment-emergent Adverse Events|Delivery of mRNA